{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:17:43Z","timestamp":1792840663274,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002647","name":"Sungkyunkwan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["21A0103L1"],"award-info":[{"award-number":["21A0103L1"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF- 2021R1A2C1092739"],"award-info":[{"award-number":["NRF- 2021R1A2C1092739"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2016R1A6A1A03011325"],"award-info":[{"award-number":["NRF-2016R1A6A1A03011325"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejps.2024.106856","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T22:06:49Z","timestamp":1721340409000},"page":"106856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["ROS-responsive thioketal nanoparticles delivering system for targeted ulcerative colitis therapy with potent HDAC6 inhibitor, tubastatin A"],"prefix":"10.1016","volume":"201","author":[{"given":"Prabhat","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Duwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooyeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeg Kyu","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7120-169X","authenticated-orcid":false,"given":"Jee-Heon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simmyung","family":"Yook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2024.106856_bib0001","first-page":"699","article-title":"Ulcerative colitis","volume":"87","author":"Adams","year":"2013","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ejps.2024.106856_bib0002","first-page":"406","article-title":"Ulcerative colitis: rapid evidence review","volume":"105","author":"Adams","year":"2022","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ejps.2024.106856_bib0003","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jconrel.2014.03.039","article-title":"Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases","volume":"183","author":"Ali","year":"2014","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.ejps.2024.106856_bib0004","first-page":"4","article-title":"Properties, functions, and secretion of human myeloperoxidase","volume":"69","author":"Arnhold","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejps.2024.106856_bib0005","doi-asserted-by":"crossref","first-page":"22955","DOI":"10.1021\/acsami.1c03594","article-title":"Hypoxia-mediated ROS amplification triggers mitochondria-mediated apoptotic cell death via PD-L1\/ROS-responsive, dual-targeted, drug-laden thioketal nanoparticles","volume":"13","author":"Banstola","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejps.2024.106856_bib0006","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2024.106856_bib0007","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejps.2024.106856_bib0008","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/1523-1747.ep12506462","article-title":"Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker","volume":"78","author":"Bradley","year":"1982","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejps.2024.106856_bib0009","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.crohns.2013.01.010","article-title":"The burden of inflammatory bowel disease in Europe","volume":"7","author":"Burisch","year":"2013","journal-title":"J. Crohn's Colitis"},{"key":"10.1016\/j.ejps.2024.106856_bib0010","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2024.106856_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120836","article-title":"Colon-targeted delivery of tacrolimus using pH-responsive polymeric nanoparticles for murine colitis therapy","volume":"606","author":"Cai","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106856_bib0012","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2021.01.044","article-title":"The role of myeloperoxidase and neutrophil extracellular traps in the pathogenesis of inflammatory bowel disease","volume":"160","author":"Chami","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2024.106856_bib0013","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/TA.0000000000001137","article-title":"Inhibition of histone deacetylase 6 restores intestinal tight junction in hemorrhagic shock","volume":"81","author":"Chang","year":"2016","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.ejps.2024.106856_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1525s104","article-title":"Dextran sulfate sodium (DSS)-induced colitis in mice","volume":"104","author":"Chassaing","year":"2014","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.ejps.2024.106856_bib0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3103\/S009639251804003X","article-title":"Role of reactive oxygen species in inflammation: a minireview","volume":"73","author":"Chelombitko","year":"2018","journal-title":"Moscow. Univ. Biol. Sci. Bull."},{"key":"10.1016\/j.ejps.2024.106856_bib0016","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bcp.2012.06.014","article-title":"Development and therapeutic impact of HDAC6-selective inhibitors","volume":"84","author":"Dallavalle","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106856_bib0017","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejps.2024.106856_bib0018","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s13346-021-00977-8","article-title":"Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases","volume":"11","author":"Deng","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2024.106856_bib0019","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/jpet.116.236711","article-title":"An HDAC6 inhibitor confers protection and selectively inhibits B-cell infiltration in DSS-induced colitis in mice","volume":"360","author":"Do","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2024.106856_bib0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2019.04.008","article-title":"Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine","volume":"143","author":"Donahue","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2024.106856_bib0021","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/d41586-018-07276-2","article-title":"Ulcerative colitis: towards remission","volume":"563","author":"Eisenstein","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2024.106856_bib0022","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/apt.13008","article-title":"Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases","volume":"41","author":"Felice","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2024.106856_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201705328","article-title":"Advances in biomaterials for drug delivery","volume":"30","author":"Fenton","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejps.2024.106856_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.649048","article-title":"Reactive oxygen species responsive polymers for drug delivery systems","volume":"9","author":"Gao","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejps.2024.106856_bib0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ibd.21681","article-title":"Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation","volume":"18","author":"Garrity-Park","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejps.2024.106856_bib0026","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2249.1999.01088.x","article-title":"Cytokines in experimental colitis","volume":"118","author":"Garside","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejps.2024.106856_bib0027","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/gut.2007.134650","article-title":"Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice","volume":"57","author":"Glauben","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.ejps.2024.106856_bib0028","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejps.2024.106856_bib0029","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/156802609788085250","article-title":"Histone deacetylase inhibitors in inflammatory disease","volume":"9","author":"Halili","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejps.2024.106856_bib0030","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2004.02.071","article-title":"Medical therapy for ulcerative colitis 2004","volume":"126","author":"Hanauer","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2024.106856_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9040420","article-title":"Phaseolin attenuates lipopolysaccharide-induced inflammation in RAW 264.7 cells and zebrafish","volume":"9","author":"Hwang","year":"2021","journal-title":"Biomedicines."},{"key":"10.1016\/j.ejps.2024.106856_bib0032","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11894-015-0466-9","article-title":"Ulcerative colitis: update on medical management","volume":"17","author":"Iskandar","year":"2015","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.ejps.2024.106856_bib0033","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00054725-200407000-00023","article-title":"Mechanisms of natural tolerance in the intestine: implications for inflammatory bowel disease","volume":"10","author":"Jump","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejps.2024.106856_bib0034","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/jm200773h","article-title":"Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells","volume":"55","author":"Kalin","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2024.106856_bib0035","doi-asserted-by":"crossref","DOI":"10.3791\/3678-v","article-title":"Investigating intestinal inflammation in DSS-induced model of IBD","author":"Kim","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejps.2024.106856_bib0036","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1538\/expanim.48.137","article-title":"Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium","volume":"48","author":"Kitajima","year":"1999","journal-title":"Exp. Anim."},{"key":"10.1016\/j.ejps.2024.106856_bib0037","first-page":"743","article-title":"Reactive oxygen metabolites and upper gastrointestinal diseases","volume":"48","author":"Kountouras","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ejps.2024.106856_bib0038","first-page":"637","article-title":"Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes","volume":"79","author":"Kozlov","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejps.2024.106856_bib0039","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12950-016-0129-0","article-title":"Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment","volume":"13","author":"Krohn","year":"2016","journal-title":"J. Inflamm."},{"key":"10.1016\/j.ejps.2024.106856_bib0040","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1023\/A:1011032328064","article-title":"Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa","volume":"18","author":"Lamprecht","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2024.106856_bib0041","article-title":"Novel histone deacetylase 6 inhibitor confers anti-inflammatory effects and enhances gut barrier function","author":"Lee","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.ejps.2024.106856_bib0042","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/adhm.201200423","article-title":"Current progress in reactive oxygen species (ROS)-responsive materials for biomedical applications","volume":"2","author":"Lee","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ejps.2024.106856_bib0043","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.415","article-title":"HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness","volume":"8","author":"Leyk","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejps.2024.106856_bib0044","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000519363","article-title":"Macrophage-biomimetic nanoparticles ameliorate ulcerative colitis through reducing inflammatory factors expression","volume":"14","author":"Li","year":"2022","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.ejps.2024.106856_bib0045","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1038\/ctg.2017.7","article-title":"Stem cell therapy for inflammatory bowel disease","volume":"8","author":"Lightner","year":"2017","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.ejps.2024.106856_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.702173","article-title":"Lentinan-based oral nanoparticle loaded budesonide with macrophage-targeting ability for treatment of ulcerative colitis","volume":"9","author":"Lin","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejps.2024.106856_bib0047","article-title":"Mechanistic investigation on oxidative degradation of ROS-responsive thioacetal\/thioketal moieties and their implications","volume":"1","author":"Liu","year":"2020","journal-title":"Cell Rep. Phys. Sci."},{"key":"10.1016\/j.ejps.2024.106856_bib0048","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12951-022-01421-w","article-title":"Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy","volume":"20","author":"Liu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejps.2024.106856_bib0049","first-page":"b16","article-title":"A highly potent and selective histone deacetylase 6 inhibitor prevents DSS-induced colitis in mice","author":"Liu","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejps.2024.106856_bib0050","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s11434-016-1056-4","article-title":"Nanoparticle-based oral delivery systems for colon targeting: principles and design strategies","volume":"61","author":"Lu","year":"2016","journal-title":"Sci. Bull."},{"key":"10.1016\/j.ejps.2024.106856_bib0051","article-title":"HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation","volume":"369","author":"Magupalli","year":"2020","journal-title":"Science (1979)"},{"key":"10.1016\/j.ejps.2024.106856_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2008.12.013","article-title":"pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model","volume":"72","author":"Makhlof","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2024.106856_bib0053","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2460\/ajvr.1999.60.07.807","article-title":"Myeloperoxidase activity of the large intestine in an equine model of acute colitis","volume":"60","author":"McConnico","year":"1999","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ejps.2024.106856_bib0054","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejps.2024.106856_bib0055","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.actbio.2022.06.024","article-title":"ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment","volume":"148","author":"Muhammad","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejps.2024.106856_bib0056","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/00365521.2016.1235224","article-title":"Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications","volume":"52","author":"Muthas","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ejps.2024.106856_bib0057","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2016.05.016","article-title":"Evaluation of a new type of nano-sized carbon monoxide donor on treating mice with experimentally induced colitis","volume":"234","author":"Nagao","year":"2016","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.ejps.2024.106856_bib0058","doi-asserted-by":"crossref","first-page":"32888","DOI":"10.1074\/jbc.M110.162743","article-title":"Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation*","volume":"285","author":"Nam","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2024.106856_bib0059","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0016-5085(90)90290-H","article-title":"A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice","volume":"98","author":"Okayasu","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2024.106856_bib0060","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ord\u00e1s","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2024.106856_bib0061","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.gtc.2020.08.003","article-title":"Assessing severity of disease in patients with ulcerative colitis","volume":"49","author":"Pabla","year":"2020","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.ejps.2024.106856_bib0062","article-title":"Mesenchymal stem cell capping on ECM-anchored caspase inhibitor-loaded PLGA microspheres for intraperitoneal injection in DSS-induced murine colitis","volume":"15","author":"Pathak","year":"2019","journal-title":"Small."},{"key":"10.1016\/j.ejps.2024.106856_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105274","article-title":"HDAC6 as privileged target in drug discovery: a perspective","volume":"163","author":"Pulya","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejps.2024.106856_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119504","article-title":"Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy","volume":"277","author":"Ramaiah","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2024.106856_bib0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/1759-7714.12974","article-title":"Targeted inhibition of histone deacetylase 6 in inflammatory diseases","volume":"10","author":"Ran","year":"2019","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.ejps.2024.106856_bib0066","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2019.11.001","article-title":"Inflammation-triggered local drug release ameliorates colitis by inhibiting dendritic cell migration and Th1\/Th17 differentiation","volume":"316","author":"Regmi","year":"2019","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.ejps.2024.106856_bib0067","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00401-013-1158-x","article-title":"Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration","volume":"126","author":"Richter-Landsberg","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejps.2024.106856_bib0068","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.prp.2008.04.011","article-title":"Oxidative stress in ulcerative colitis-associated carcinogenesis","volume":"204","author":"Roessner","year":"2008","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ejps.2024.106856_bib0069","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.canlet.2013.07.032","article-title":"Chronic ulcerative colitis and colorectal cancer","volume":"345","author":"Rogler","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejps.2024.106856_bib0070","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1590-8658(04)00088-X","article-title":"The use of the anti-tumour necrosis factor monoclonal antibody\u2014Infliximab\u2014To treat ulcerative colitis: implications and trends beyond the available data","volume":"36","author":"Rossetti","year":"2004","journal-title":"Digest. Liver Dis."},{"key":"10.1016\/j.ejps.2024.106856_bib0071","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/0091270007301623","article-title":"The role of TNFalpha in ulcerative colitis","volume":"47","author":"Sands","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106856_bib0072","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejps.2024.106856_bib0073","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1136\/gut.34.9.1191","article-title":"Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis","volume":"34","author":"Sedghi","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.ejps.2024.106856_bib0074","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.it.2011.04.001","article-title":"Histone deacetylases as regulators of inflammation and immunity","volume":"32","author":"Shakespear","year":"2011","journal-title":"Trends. Immunol."},{"key":"10.1016\/j.ejps.2024.106856_bib0075","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1021\/acsmedchemlett.9b00560","article-title":"Structural and in Vivo Characterization of Tubastatin A, a Widely Used Histone Deacetylase 6 Inhibitor","volume":"11","author":"Shen","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2024.106856_bib0076","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3748\/wjg.14.390","article-title":"Immunopathogenesis of inflammatory bowel disease","volume":"14","author":"Shih","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejps.2024.106856_bib0077","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1002\/anie.201209633","article-title":"A reactive oxygen species (ROS)-responsive polymer for safe, efficient, and targeted gene delivery in cancer cells","volume":"52","author":"Shim","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejps.2024.106856_bib0078","doi-asserted-by":"crossref","first-page":"S015","DOI":"10.1093\/ecco-jcc\/jjy222.022","article-title":"OP23 CKD-506, a novel histone deacetylase (HDAC) 6 inhibitor, ameliorates colitis in various animal models","volume":"13","author":"Shin","year":"2019","journal-title":"J. Crohn's Colitis"},{"key":"10.1016\/j.ejps.2024.106856_bib0079","first-page":"117","article-title":"Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome","volume":"51","author":"Silberer","year":"2005","journal-title":"Clin. Lab."},{"key":"10.1016\/j.ejps.2024.106856_bib0080","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ueg2.12319","article-title":"Environmental risk factors for inflammatory bowel disease","volume":"10","author":"Singh","year":"2022","journal-title":"United. European. Gastroenterol. J."},{"key":"10.1016\/j.ejps.2024.106856_bib0081","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","article-title":"Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases","volume":"140","author":"Strober","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2024.106856_bib0082","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1039\/C7OB01975K","article-title":"A ROS-responsive polymeric micelle with a \u03c0-conjugated thioketal moiety for enhanced drug loading and efficient drug delivery","volume":"15","author":"Sun","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejps.2024.106856_bib0083","article-title":"ROS-responsive nanoparticles for oral delivery of luteolin and targeted therapy of ulcerative colitis by regulating pathological microenvironment","volume":"14","author":"Tan","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ejps.2024.106856_bib0084","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tcb.2008.04.003","article-title":"HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions","volume":"18","author":"Valenzuela-Fern\u00e1ndez","year":"2008","journal-title":"Trends. Cell Biol."},{"key":"10.1016\/j.ejps.2024.106856_bib0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.intimp.2013.03.016","article-title":"Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects","volume":"16","author":"Vishwakarma","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejps.2024.106856_bib0086","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2013.07.031","article-title":"Surfactant-dependence of nanoparticle treatment in murine experimental colitis","volume":"172","author":"Wachsmann","year":"2013","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.ejps.2024.106856_bib0087","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/ibd\/izab277","article-title":"Excessive apoptosis in ulcerative colitis: crosstalk between apoptosis, ROS, ER stress, and intestinal homeostasis","volume":"28","author":"Wan","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejps.2024.106856_bib0088","article-title":"Microtubule acetylation amplifies p38 kinase signalling and anti-inflammatory IL-10 production","author":"Wang","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2024.106856_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111276","article-title":"Preparation of ROS-responsive core crosslinked polycarbonate micelles with thioketal linkage","volume":"195","author":"Wang","year":"2020","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ejps.2024.106856_bib0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.intimp.2018.01.039","article-title":"Inhibition of histone deacetylase reduces lipopolysaccharide-induced-inflammation in primary mammary epithelial cells by regulating ROS-NF-\u043aB signaling pathways","volume":"56","author":"Wang","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejps.2024.106856_bib0091","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nmat2859","article-title":"Orally delivered thioketal nanoparticles loaded with TNF-\u03b1\u2013siRNA target inflammation and inhibit gene expression in the intestines","volume":"9","author":"Wilson","year":"2010","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ejps.2024.106856_bib0092","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically induced mouse models of intestinal inflammation","volume":"2","author":"Wirtz","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejps.2024.106856_bib0093","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","article-title":"HDAC family: what are the cancer relevant targets?","volume":"277","author":"Witt","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejps.2024.106856_bib0094","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2024.106856_bib0095","doi-asserted-by":"crossref","first-page":"FDD53","DOI":"10.4155\/fdd-2020-0023","article-title":"Recent advances in small molecular modulators targeting histone deacetylase 6","volume":"2","author":"Xiao","year":"2020","journal-title":"Future Drug Discov."},{"key":"10.1016\/j.ejps.2024.106856_bib0096","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/mabi.201500440","article-title":"Reactive Oxygen Species (ROS) responsive polymers for biomedical applications","volume":"16","author":"Xu","year":"2016","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejps.2024.106856_bib0097","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110718","article-title":"HDAC6 deacetylase activity is critical for lipopolysaccharide-induced activation of macrophages","volume":"9","author":"Yan","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejps.2024.106856_bib0098","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2016.05.014","article-title":"Overexpression of HDAC6 induces pro-inflammatory responses by regulating ROS-MAPK-NF-\u03baB\/AP-1 signaling pathways in macrophages","volume":"97","author":"Youn","year":"2016","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.ejps.2024.106856_bib0099","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1039\/D2NR04968F","article-title":"Programmed pH-responsive core-shell nanoparticles for precisely targeted therapy of ulcerative colitis","volume":"15","author":"Zhang","year":"2023","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejps.2024.106856_bib0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ecco-jcc\/jjx115","article-title":"Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of ulcerative colitis","volume":"12","author":"Zhang","year":"2018","journal-title":"J. Crohns. Colitis."},{"key":"10.1016\/j.ejps.2024.106856_bib0101","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.biomaterials.2016.08.010","article-title":"A superoxide dismutase\/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease","volume":"105","author":"Zhang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2024.106856_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109166","article-title":"Inhibition of HDAC6 attenuates LPS-induced inflammation in macrophages by regulating oxidative stress and suppressing the TLR4-MAPK\/NF-\u03baB pathways","volume":"117","author":"Zhang","year":"2019","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.ejps.2024.106856_bib0103","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.719390","article-title":"Role of HDAC6 and its selective inhibitors in gastrointestinal cancer","volume":"9","author":"Zhou","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejps.2024.106856_bib0104","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.2147\/DDDT.S170676","article-title":"Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis","author":"Zhou","year":"2018","journal-title":"Drug Des. Devel. Ther."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:57:07Z","timestamp":1778558227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724001684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":104,"alternative-id":["S0928098724001684"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106856","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ROS-responsive thioketal nanoparticles delivering system for targeted ulcerative colitis therapy with potent HDAC6 inhibitor, tubastatin A","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106856"}}